BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37645984)

  • 21. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
    Maher D; Mwandumba H
    J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality.
    Skipper CP; Hullsiek KH; Stadelman A; Williams DA; Ssebambulidde K; Okafor E; Tugume L; Nuwagira E; Akampurira A; Musubire AK; Abassi M; Muzoora C; Rhein J; Boulware DR; Meya DB
    J Fungi (Basel); 2022 Dec; 9(1):. PubMed ID: 36675867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts.
    Tugume L; Rhein J; Hullsiek KH; Mpoza E; Kiggundu R; Ssebambulidde K; Schutz C; Taseera K; Williams DA; Abassi M; Muzoora C; Musubire AK; Meintjes G; Meya DB; Boulware DR;
    J Infect Dis; 2019 Feb; 219(6):877-883. PubMed ID: 30325463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal Meningitis.
    Rhein J; Bahr NC; Morawski BM; Schutz C; Zhang Y; Finkelman M; Meya DB; Meintjes G; Boulware DR
    Open Forum Infect Dis; 2014 Dec; 1(3):ofu105. PubMed ID: 25734173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis.
    Marais S; Meintjes G; Lesosky M; Wilkinson KA; Wilkinson RJ
    AIDS; 2016 Jan; 30(3):395-404. PubMed ID: 26765934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic and cerebrospinal fluid T-helper cytokine responses in organ transplant recipients with Cryptococcus neoformans infection.
    Singh N; Husain S; Limaye AP; Pursell K; Klintmalm GB; Pruett TL; Somani J; Stosor V; del Busto R; Wagener MM; Steele C
    Transpl Immunol; 2006 Aug; 16(2):69-72. PubMed ID: 16860707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.
    Loyse A; Wilson D; Meintjes G; Jarvis JN; Bicanic T; Bishop L; Rebe K; Williams A; Jaffar S; Bekker LG; Wood R; Harrison TS
    Clin Infect Dis; 2012 Jan; 54(1):121-8. PubMed ID: 22052885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma But Not Cerebrospinal Fluid Interleukin 7 and Interleukin 5 Levels Pre-Antiretroviral Therapy Commencement Predict Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Akilimali NA; Chang CC; Muema DM; Reddy T; Moosa MS; Lewin SR; French MA; Ndung'u T
    Clin Infect Dis; 2017 Oct; 65(9):1551-1559. PubMed ID: 29048509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana.
    Kelentse N; Moyo S; Molebatsi K; Morerinyane O; Bitsang S; Bareng OT; Lechiile K; Leeme TB; Lawrence DS; Kasvosve I; Musonda R; Mosepele M; Harrison TS; Jarvis JN; Gaseitsiwe S
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of HIV-1 in cerebrospinal fluid and plasma in cryptococcal meningitis.
    Cecchini DM; Cañizal AM; Rojas H; Arechavala A; Negroni R; Bouzas MB; Benetucci JA
    Infect Dis Rep; 2012 Apr; 4(2):e30. PubMed ID: 24470944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal Meningitis.
    Kasibante J; Irfanullah E; Wele A; Okafor E; Ssebambulidde K; Okurut S; Kagimu E; Gakuru J; Rutakingirwa MK; Mugabi T; Nuwagira E; Jjunju S; Mpoza E; Tugume L; Nsangi L; Musibire AK; Muzoora C; Rhein J; Meya DB; Boulware DR; Abassi M
    medRxiv; 2023 Dec; ():. PubMed ID: 38168371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a machine learning model to predict prognosis in HIV-negative cryptococcal meningitis patients: a multicenter study.
    Liu J; Lu Y; Liu J; Liang J; Zhang Q; Li H; Zhong X; Bu H; Wang Z; Fan L; Liang P; Xie J; Wang Y; Gong J; Chen H; Dai Y; Yang L; Su X; Wang A; Xiong L; Xia H; Jiang Y; Liu Z; Peng F
    Eur J Clin Microbiol Infect Dis; 2023 Oct; 42(10):1183-1194. PubMed ID: 37606868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment for HIV-associated cryptococcal meningitis.
    Tenforde MW; Shapiro AE; Rouse B; Jarvis JN; Li T; Eshun-Wilson I; Ford N
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD005647. PubMed ID: 30045416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
    Eshun-Wilson I; Okwen MP; Richardson M; Bicanic T
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009012. PubMed ID: 30039850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis.
    Kwizera R; Akampurira A; Kandole TK; Nielsen K; Kambugu A; Meya DB; Boulware DR; Rhein J;
    BMC Microbiol; 2017 Aug; 17(1):182. PubMed ID: 28830348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of elevated intracranial pressure in patients with Cryptococcal meningitis.
    Fessler RD; Sobel J; Guyot L; Crane L; Vazquez J; Szuba MJ; Diaz FG
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):137-42. PubMed ID: 9473014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension in patients with HIV-associated cryptococcal meningitis with or without hydrocephalus.
    Liu L; Zhang R; Tang Y; Lu H
    Biosci Trends; 2014 Dec; 8(6):327-32. PubMed ID: 25641179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study.
    Wan Z; Tao R; Hui J; Liu X; Peng X; Guo Y; Zhu X; Huang Y; Zhu B
    J Neuroinflammation; 2023 Feb; 20(1):38. PubMed ID: 36793113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures.
    Bicanic T; Brouwer AE; Meintjes G; Rebe K; Limmathurotsakul D; Chierakul W; Teparrakkul P; Loyse A; White NJ; Wood R; Jaffar S; Harrison T
    AIDS; 2009 Mar; 23(6):701-6. PubMed ID: 19279443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis.
    Panackal AA; Wuest SC; Lin YC; Wu T; Zhang N; Kosa P; Komori M; Blake A; Browne SK; Rosen LB; Hagen F; Meis J; Levitz SM; Quezado M; Hammoud D; Bennett JE; Bielekova B; Williamson PR
    PLoS Pathog; 2015 May; 11(5):e1004884. PubMed ID: 26020932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.